Disease Markers

Table of Contents: 2010

  • Disease Markers -
  • Special Issue
  • Volume 28
  • - Article ID 319647

Potential Influence of Interleukin-1 Receptor Antagonist Gene Polymorphism on Knee Osteoarthritis Risk

Menha Swellam | Magda Sayed Mahmoud | ... | Ali Ahmed Gamal
  • Disease Markers -
  • Special Issue
  • Volume 28
  • - Article ID 216046

Functional Inference of Methylenetetrahydrofolate Reductase Gene Polymorphisms on Enzyme Stability as a Potential Risk Factor for Down Syndrome in Croatia

Jadranka Vraneković | Ivana Babić Božović | ... | Bojana Brajenović-Milić
  • Disease Markers -
  • Special Issue
  • Volume 29
  • - Article ID 504039

Matrix Metalloproteinases 2 and 3 Gene Polymorphisms and the Risk of Target Vessel Revascularization after Percutaneous Coronary Intervention: Is There Still Room for Determining Genetic Variation of MMPs for Assessment of an Increased Risk of Restenosis?

J.J.W. Verschuren | M.L. Sampietro | ... | J.W. Jukema
  • Disease Markers -
  • Special Issue
  • Volume 28
  • - Article ID 530360

Multiplex Ligation-Dependent Probe Amplification Analysis of GATA4 Gene Copy Number Variations in Patients with Isolated Congenital Heart Disease

Valentina Guida | Francesca Lepri | ... | Bruno Dallapiccola
  • Disease Markers -
  • Special Issue
  • Volume 29
  • - Article ID 501730

Homozygosity for the Ala Allele of the PPARγ2 Pro12Ala Polymorphism Is Associated with Reduced Risk of Coronary Artery Disease

Andrea Galgani | AnaMaria Valdes | ... | Raffaella Buzzetti
  • Disease Markers -
  • Special Issue
  • Volume 29
  • - Article ID 470314

14-3-3 Sigma And p53 Expression in Gastric Cancer and Its Clinical Applications

Gilbert Mühlmann | Dietmar Öfner | ... | Albert Amberger
  • Disease Markers -
  • Special Issue
  • Volume 28
  • - Article ID 439048

Interleukin-6 Gene Promoter Polymorphisms and Cardiovascular Risk Factors. A family study

Iris Paola Guzmán-Guzmán | José Francisco Muñoz-Valle | ... | Isela Parra-Rojas
  • Disease Markers -
  • Special Issue
  • Volume 28
  • - Article ID 246845

Analysis of Osteocalcin as a Candidate Gene for Type 2 Diabetes (T2D) and Intermediate Traits in Caucasians and African Americans

Swapan K. Das | Neeraj K. Sharma | Steven C. Elbein
  • Disease Markers -
  • Special Issue
  • Volume 29
  • - Article ID 474692

Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma

Hong-Qiang Guo | Guo-Liang Huang | ... | Tong-Yu Lin
  • Disease Markers -
  • Special Issue
  • Volume 28
  • - Article ID 706984

Decreased IP-10 and Elevated TGFβ1 Levels are Associated with Viral Clearance Following Therapy in Patients with Hepatitis C Virus

Silvia Lee | Julius Varano | ... | Patricia Price
  • Disease Markers -
  • Special Issue
  • Volume 29
  • - Article ID 432462

Rapid Genotyping of the Human Renin (REN) Gene by the LightCycler® Instrument: Identification of Unexpected Nucleotide Substitutions within the Selected Hybridization Probe Area

Line Wee | Hege Vefring | ... | Rolv Terje Lie
  • Disease Markers -
  • Special Issue
  • Volume 28
  • - Article ID 128654

Progression Model Tissue Microarray (TMA) for the Study of Uterine Carcinomas

Mohammad Arafa | Jacques Boniver | Philippe Delvenne
  • Disease Markers -
  • Special Issue
  • Volume 29
  • - Article ID 308784

The PCA and LDA Analysis on the Differential Expression of Proteins in Breast Cancer

Seng Liang | Manjit Singh | ... | Lay-Harn Gam
  • Disease Markers -
  • Special Issue
  • Volume 29
  • - Article ID 280987

No Direct Association of Serotonin Transporter (STin2 VNTR) and Receptor (HT 102T>C) Gene Variants in Genetic Susceptibility to Migraine

Gunjan Joshi | Sunil Pradhan | Balraj Mittal
  • Disease Markers -
  • Special Issue
  • - Volume 28
  • - Article ID 708932

Separating the Drivers from the Driven: Integrative Network and Pathway Approaches Aid Identification of Disease Biomarkers from High-Throughput Data

Jason E. McDermott | Michelle Costa | ... | Susan C. Tilton
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.